ALTIMMUNE, INC. Accounts Payable
ALTIMMUNE, INC. (ALT) had Accounts Payable of $1.27 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $1.27M.
- 2026-03-31: Accounts Payable, Current $1.53M.
- 2025-12-31: Accounts Payable, Current $2.72M.
- 2025-09-30: Accounts Payable, Current $4.80M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.27M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.53M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.72M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $4.80M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $851.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $1.08M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $211.00K 10-K · filed 2026-03-06 | |
| 2024-09-30 | $1.13M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.69M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.76M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $2.07M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $3.05M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $4.04M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $5.24M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $4.80M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $1.42M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.87M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.21M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.03M 10-K · filed 2023-02-28 | $2.03M 10-K · filed 2022-03-15 |
| 2021-09-30 | $6.08K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.42M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $418.24K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $612.29K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $874.88K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $195.22K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $929.63K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $18.23K 10-K · filed 2021-02-25 | |
| 2019-09-30 | $49.88K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $270.10K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $14.75K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $372.86K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $150.74K 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $245.25K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $513.17K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $129.07K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $495.06K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.13M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $839.47K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $2.01M 10-K · filed 2018-04-02 | $926.53K 10-K · filed 2017-03-14 |
| 2016-09-30 | $614.54K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $711.11K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $166.36K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $521.12K 10-K · filed 2017-03-14 | |
| 2015-09-30 | $306.17K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $208.46K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $536.99K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $391.40K 10-K · filed 2016-03-11 | |
| 2014-09-30 | $282.02K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $437.38K 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $471.80K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $1.13M 10-K · filed 2015-03-11 | |
| 2013-09-30 | $1.16M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $2.99M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $1.29M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.70M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $1.85M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $2.06M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $1.41M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $1.45M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $445.51K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $2.48M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $3.13M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |